Sanofi SA (NYSE:SNY)
| 54.95 Real-Time Quote |  +1.11 / +2.06%Today’s Change | 33.03 Today|||52-Week Range 55.77 | +15.98% Year-to-Date |
Latest SNY News | Press Releases
| Sanofi (SNY): Today's Featured Drugs Laggard May 20 / TheStreet.com | Isis Reports In-Line Loss - Analyst Blog May 08 / Zacks.com |
| 5 Stocks Underperforming Today In The Drugs Industry May 20 / TheStreet.com | Osiris Loss In-Line with Expectations - Analyst Blog May 08 / Zacks.com |
| Sanofi/REGN Commence Enrollment - Analyst Blog May 15 / Zacks.com | MYGN Earnings Easily Beat, Guidance Up - Analyst Blog May 08 / Zacks.com |
| FDA Accepts Merck BLA - Analyst Blog May 15 / Zacks.com | Merck's Liptruzet Approved in the US - Analyst Blog May 07 / Zacks.com |
| Narrower than Expected Loss at Infinity - Analyst Blog May 09 / Zacks.com | European drug stocks are on a tear Apr 24 / CNNMoney.com |
Today’s Trading
| Previous close | 53.84 |
| Today’s open | 54.32 |
| Day’s range | 54.19 - 55.03 |
| Volume | 426,051 |
| Average volume (3 months) | 2,578,740 |
| Market cap | $142.5B |
| Dividend yield | 3.08% |
Data as of 12:13pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | -19.51% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +6.00% |
| Revenue growth (last year) | -3.43% |
| P/E ratio | -- |
| Price/Sales | 2.77 |
| Price/Book | 1.88 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck & Co Inc | +0.59 | +1.29% |
| GSKGlaxoSmithKline PLC | +0.46 | +0.88% |
| NVSNovartis AG | +0.38 | +0.51% |
| PFEPfizer Inc | -0.22 | -0.77% |
Data as of 12:15pm ET, 05/21/2013
Financials
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $0.91 |
| Annual revenue (last year) | $45.1B |
| Annual profit (last year) | $6.4B |
| Net profit margin | 14.21% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Director Christopher A. Viehbacher, CPA |
President- Global Operations Hanspeter Spek |
Corporate headquarters Paris, Ile-de-france |
Forecasts
